Literature DB >> 7568134

Expression of human beta-amyloid peptide in transgenic Caenorhabditis elegans.

C D Link1.   

Abstract

Transgenic Caenorhabditis elegans nematodes have been engineered to express potentially amyloidic human proteins. These animals contain constructs in which the muscle-specific unc-54 promoter/enhancer of C. elegans drives the expression of the appropriate coding regions derived from human cDNA clones. Animals containing constructs expressing the 42-amino acid beta-amyloid peptide (derived from human amyloid precursor protein cDNA) produce muscle-specific deposits immunoreactive with anti-beta-amyloid polyclonal and monoclonal antibodies. A subset of these deposits also bind the amyloid-specific dye thioflavin S, indicating that these deposits have the tinctural characteristics of classic amyloid. Co-expression of beta-peptide and transthyretin, a protein implicated in preventing the formation of insoluble beta-amyloid, leads to a dramatic reduction in the number of dye-reactive deposits. These results suggest that this invertebrate model may be useful for in vivo investigation of factors that modulate amyloid formation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7568134      PMCID: PMC40986          DOI: 10.1073/pnas.92.20.9368

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  41 in total

1.  The transthyretin cDNA sequence is normal in transthyretin-derived senile systemic amyloidosis.

Authors:  L Christmanson; C Betsholtz; A Gustavsson; B Johansson; K Sletten; P Westermark
Journal:  FEBS Lett       Date:  1991-04-09       Impact factor: 4.124

2.  Theoretical models of the ion channel structure of amyloid beta-protein.

Authors:  S R Durell; H R Guy; N Arispe; E Rojas; H B Pollard
Journal:  Biophys J       Date:  1994-12       Impact factor: 4.033

3.  A general method of in vitro preparation and specific mutagenesis of DNA fragments: study of protein and DNA interactions.

Authors:  R Higuchi; B Krummel; R K Saiki
Journal:  Nucleic Acids Res       Date:  1988-08-11       Impact factor: 16.971

Review 4.  Familial amyloidotic polyneuropathy.

Authors:  M D Benson
Journal:  Trends Neurosci       Date:  1989-03       Impact factor: 13.837

5.  Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type.

Authors:  E Levy; M D Carman; I J Fernandez-Madrid; M D Power; I Lieberburg; S G van Duinen; G T Bots; W Luyendijk; B Frangione
Journal:  Science       Date:  1990-06-01       Impact factor: 47.728

6.  Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein.

Authors:  G G Glenner; C W Wong
Journal:  Biochem Biophys Res Commun       Date:  1984-05-16       Impact factor: 3.575

7.  A modular set of lacZ fusion vectors for studying gene expression in Caenorhabditis elegans.

Authors:  A Fire; S W Harrison; D Dixon
Journal:  Gene       Date:  1990-09-14       Impact factor: 3.688

8.  Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease.

Authors:  A Goate; M C Chartier-Harlin; M Mullan; J Brown; F Crawford; L Fidani; L Giuffra; A Haynes; N Irving; L James
Journal:  Nature       Date:  1991-02-21       Impact factor: 49.962

9.  Formation of beta-amyloid protein deposits in brains of transgenic mice.

Authors:  D Quon; Y Wang; R Catalano; J M Scardina; K Murakami; B Cordell
Journal:  Nature       Date:  1991-07-18       Impact factor: 49.962

10.  A new A4 amyloid mRNA contains a domain homologous to serine proteinase inhibitors.

Authors:  P Ponte; P Gonzalez-DeWhitt; J Schilling; J Miller; D Hsu; B Greenberg; K Davis; W Wallace; I Lieberburg; F Fuller
Journal:  Nature       Date:  1988-02-11       Impact factor: 49.962

View more
  234 in total

Review 1.  Modeling human neurodegenerative diseases in transgenic systems.

Authors:  Miguel A Gama Sosa; Rita De Gasperi; Gregory A Elder
Journal:  Hum Genet       Date:  2011-12-14       Impact factor: 4.132

2.  Neurotoxic effects of TDP-43 overexpression in C. elegans.

Authors:  Peter E A Ash; Yong-Jie Zhang; Christine M Roberts; Tassa Saldi; Harald Hutter; Emanuele Buratti; Leonard Petrucelli; Christopher D Link
Journal:  Hum Mol Genet       Date:  2010-06-08       Impact factor: 6.150

Review 3.  Genetics, life span, health span, and the aging process in Caenorhabditis elegans.

Authors:  Heidi A Tissenbaum
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2012-04-12       Impact factor: 6.053

4.  Fluoxetine protects against amyloid-beta toxicity, in part via daf-16 mediated cell signaling pathway, in Caenorhabditis elegans.

Authors:  Roongpetch Keowkase; Marwa Aboukhatwa; Yuan Luo
Journal:  Neuropharmacology       Date:  2010-04-24       Impact factor: 5.250

Review 5.  Pharmacological lifespan extension of invertebrates.

Authors:  Mark Lucanic; Gordon J Lithgow; Silvestre Alavez
Journal:  Ageing Res Rev       Date:  2012-07-06       Impact factor: 10.895

6.  Investigating heart-specific toxicity of amyloidogenic immunoglobulin light chains: A lesson from C. elegans.

Authors:  Luisa Diomede; Paola Rognoni; Francesca Lavatelli; Margherita Romeo; Andrea di Fonzo; Claudia Foray; Fabio Fiordaliso; Giovanni Palladini; Veronica Valentini; Vittorio Perfetti; Mario Salmona; Giampaolo Merlini
Journal:  Worm       Date:  2014-10-30

7.  Genome-wide RNA interference screen identifies previously undescribed regulators of polyglutamine aggregation.

Authors:  Ellen A A Nollen; Susana M Garcia; Gijs van Haaften; Soojin Kim; Alejandro Chavez; Richard I Morimoto; Ronald H A Plasterk
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-14       Impact factor: 11.205

8.  Reduced IGF-1 signaling delays age-associated proteotoxicity in mice.

Authors:  Ehud Cohen; Johan F Paulsson; Pablo Blinder; Tal Burstyn-Cohen; Deguo Du; Gabriela Estepa; Anthony Adame; Hang M Pham; Martin Holzenberger; Jeffery W Kelly; Eliezer Masliah; Andrew Dillin
Journal:  Cell       Date:  2009-12-11       Impact factor: 41.582

Review 9.  Understanding the molecular basis of Alzheimer's disease using a Caenorhabditis elegans model system.

Authors:  Collin Y Ewald; Chris Li
Journal:  Brain Struct Funct       Date:  2009-12-11       Impact factor: 3.270

Review 10.  Modeling molecular and cellular aspects of human disease using the nematode Caenorhabditis elegans.

Authors:  Gary A Silverman; Cliff J Luke; Sangeeta R Bhatia; Olivia S Long; Anne C Vetica; David H Perlmutter; Stephen C Pak
Journal:  Pediatr Res       Date:  2009-01       Impact factor: 3.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.